Israel Englander’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Israel Englander’s Portfolio MRNS Stock Details MRNS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-32,100	Closed	-$290K	–	6750
2024 Q1	$290K	Buy	+32,100	New	+$312K	﹤0.01%	5161

Israel Englander's MRNS Position: Q1 2025 in Review

Israel Englander sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2025, closing a stake of 239,414 shares — an estimated $128K sold.

Israel Englander first reported a position in MRNS in Q3 2014 and held it in 21 quarters. The position peaked at $7.47M in Q4 2017. 0 funds tracked by Wall St. Rank hold MRNS as of Q1 2025.

Israel Englander reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2025 after selling out during the quarter.
Israel Englander sold 239,414 Marinus Pharmaceuticals, Inc shares in Q1 2025, an estimated $128K.
Israel Englander first reported a position in Marinus Pharmaceuticals, Inc in Q3 2014 and held it in 21 quarters.
Israel Englander's Marinus Pharmaceuticals, Inc position peaked at $7.47M in Q4 2017.
0 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2025.

Based on Millennium Management's 13F filing for Q1 2025, filed 15 May 2025.